中国组织工程研究 ›› 2026, Vol. 30 ›› Issue (17): 4487-4497.doi: 10.12307/2026.196

• 组织工程相关大数据分析 Big data analysis in tissue engineering • 上一篇    下一篇

芳香温通法配伍干预防治心脏组织炎性衰老

何  嘉1,2,3,朱伟东1,2,陈立典3,任丹妮1,2   

  1. 福建中医药大学,1中西医结合学院,中西医结合研究院,3康复产业研究院,福建省福州市   350122;2福建省中西医结合老年性疾病重点实验室,福建省福州市   350122
  • 收稿日期:2025-08-22 接受日期:2025-08-25 出版日期:2026-06-18 发布日期:2025-12-03
  • 通讯作者: 任丹妮,博士,教授,福建中医药大学,中西医结合学院,中西医结合研究院,福建省福州市 350122;福建省中西医结合老年性疾病重点实验室,福建省福州市 350122 共同通讯作者:陈立典,博士,教授,福建中医药大学康复产业研究院,福建省福州市 350122
  • 作者简介:何嘉,女,1993年生,广东省深圳市人,汉族,博士,医学博士后,主要从事中西医结合防治心血管研究。
  • 基金资助:
    国家自然科学基金项目(82305026),项目负责人:何嘉;福建省自然科学基金项目(2024J08205),项目负责人:何嘉;福建中医药大学青年科研拔尖人才项目(XQB202201),项目负责人:任丹妮;福建中医药大学高层次人才科研项目(2021003-人才),项目负责人:任丹妮

Compatibility strategy of Fangxiang Wentong method drug pairs for the prevention and treatment of myocardial inflammaging

He Jia1, 2, 3, Zhu Weidong1, 2, Chen Lidian3, Ren Danni1, 2   

  1. 1Academy of Integrative Medicine, College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian Province, China; 2Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fuzhou 350122, Fujian Province, China; 3College of Rehabilitation Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian Province, China
  • Received:2025-08-22 Accepted:2025-08-25 Online:2026-06-18 Published:2025-12-03
  • Contact: Ren Danni, PhD, Professor, Academy of Integrative Medicine, College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian Province, China; Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fuzhou 350122, Fujian Province, China Co-corresponding author: Chen Lidian, PhD, Professor, College of Rehabilitation Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian Province, China
  • About author:He Jia, MD, Academy of Integrative Medicine, College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian Province, China; Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fuzhou 350122, Fujian Province, China; College of Rehabilitation Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, Fujian Province, China
  • Supported by:
    National Natural Science Foundation of China, No. 82305026 (to HJ); Fujian Provincial Natural Science Foundation, No. 2024J08205 (to HJ); Young Outstanding Research Talent Project of Fujian University of Traditional Chinese Medicine, No. XQB202201 (to RDN); High-Level Talent Research Project of Fujian University of Traditional Chinese Medicine, No. 2021003-Talent (to RDN)

摘要:



文题释义:
芳香温通法:为中医治疗心血管疾病的特色疗法,利用药物辛香走窜、温热祛寒的特性,通过宣通郁闭的气机、温散凝滞的寒邪、解痉通络快速疏通(气机、血脉、经络)通道,解除因寒凝气滞引起的疼痛与闭阻之证的一种治法。
心脏衰老:指心脏随年龄增长发生的系列结构重塑和功能变化。寻找能够反映心脏衰老水平的生物标志物,有助于精准评估个体心脏的功能状态、预测发生心脏衰老相关疾病的风险。

背景:炎性衰老是自然衰老进程中机体呈现的低水平促炎状态,与心血管疾病等相关增龄性疾病的发生密切相关,目前尚缺乏以心脏炎性衰老为核心机制进行系统阐释的理论框架。
目的:应用数据挖掘和网络药理学方法分析中医古籍中治疗心脏衰老的遣方用药规律,探索核心药物可能的作用机制。
方法:①收集和整理从《中华人民共和国药典》2020年版、《中药学》第10版教材及《中医方剂大辞典》收录的中医古代医典著作中治疗心脏衰老病的方剂,对它们进行中药频数性味归经统计、关联规则分析以及聚类分析,筛选治疗心脏衰老的核心药对。进一步建立核心药对-活性成分-疾病-共有靶点网络模型,进行GO富集分析和KEGG信号通路分析。此外,借助分子对接及动力学模拟评估潜在关键靶标与活性成分之间的结合能力与稳定性。②验证实验:将60只C57BL/6小鼠随机分为3组干预:空白组(n=20)灌胃给予蒸馏水,麝香-附子低剂量组(n=20)灌胃给予2.64 g/kg麝香-附子,麝香-附子高剂量组(n=20)灌胃给予5.28 g/kg麝香-附子,每天1次,连续给药7 d。末次给药结束后,眼眶取血分离血清,分别获得不含药血清与麝香-附子低、高剂量含药血清。将第3代人心室肌细胞株AC16分3组处理,分别加入不含药血清与麝香-附子低、高剂量含药血清,CCK-8法检测细胞活力。将第3代人心室肌细胞株AC16分4组处理,对照组加入PBS;其余3组分别加入不含药血清与麝香-附子低、高剂量含药血清处理48 h,然后加入肿瘤坏死因子α处理4 h(诱导炎症模型),Western Blot检测核因子κB抑制蛋白、磷酸化核因子κB抑制蛋白、核因子κB p65、核因子κB p50蛋白表达。
结果与结论:①从《中华人民共和国药典》2020年版中共发现268首方剂,剔除不同著作中重复收录及非治疗心脏衰老处方后,最终筛选出88首方剂,涉及36味中药。其中,药物使用频数较高的为肉桂、干姜、附子、薤白、麝香,这些药物性味以辛温为主,归心、肾和肝经,以芳香温通法治则为主。关联规则分析共得到4条强关联药组,支持度较高的为“麝香-附子”“肉桂-干姜”“干姜-附子”和“薤白-瓜蒌”(置信度≥90%),因子分析共提取4个公因子,体现了历代医家芳香温通的治疗思想,这4个核心药对可能通过影响炎症信号通路来减缓心脏衰老,它们的作用与心脏衰老标志物炎症占比较高相关。选取药对麝香-附子进行分子对接,结果显示关键靶点与该药对核心成分之间具有良好的结合能力及稳定性。②CCK-8检测显示,麝香-附子药对含药血清具有较高的细胞相容性。Western Blot检测显示,与对照组相比,肿瘤坏死因子α干预能显著导致核因子κB抑制蛋白磷酸化,释放核因子κB(p65/p50的二聚体)转入细胞核,表明炎症损伤模型建立成功;而麝香-附子药对低、高剂量含药血清干预能明显抑制肿瘤坏死因子α诱导的核因子κB抑制蛋白及细胞核中核因子κB(p65/p50)的上调。③结果表明,中医古籍中治疗心脏衰老主要以芳香温通法为治疗原则,其中以麝香-附子核心药对为主,该药对可能通过抑制炎性信号延缓心脏衰老的发展。

https://orcid.org/0000-0002-1476-0129 (何嘉) 


中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

关键词: 芳香温通法, 心脏炎性衰老, 药对, 用药规律, 麝香-附子, 炎症信号

Abstract: BACKGROUND: Inflammaging, characterized by a chronic low-grade pro-inflammatory state during natural aging, is closely associated with the development of age-related diseases such as cardiovascular disorders. However, a systematic theoretical framework centered on cardiac inflammaging as a core pathological mechanism is still lacking. 
OBJECTIVE: To analyze the prescription patterns and medication principles for treating cardiac aging in traditional Chinese medicine (TCM) classics using data mining and network pharmacology methods, and to explore the potential mechanisms of core drugs. 
METHODS: (1) Formulations for treating cardiac aging were collected and compiled from the 2020 edition of the Pharmacopoeia of the People's Republic of China, the 10th edition of Chinese Materia Medica, and the Comprehensive Dictionary of TCM Prescriptions. The frequency of medicinal herbs, their properties, and meridian affinity were statistically analyzed, along with association rule analysis and clustering, to identify core herb pairs for treating cardiac aging. A core herb pair-active ingredient-disease-common target network model was established, followed by gene ontology enrichment analysis and Kyoto Encyclopedia of Genes and Genomes pathway analysis. In addition, molecular docking and dynamic simulation were employed to assess the binding ability and stability between potential key targets and active ingredients. (2) Validation experiment: Sixty C57BL/6 mice were randomly divided into three intervention groups: the blank group (n=20) was administered distilled water via gavage, the low-dose musk-aconite group (n=20) was administered 2.64 g/kg musk-aconite via gavage, and the high-dose musk-aconite group (n=20) was administered 5.28 g/kg musk-aconite group via gavage, once daily for 7 consecutive days. After the final administration, blood was collected from the orbital sinus, and serum was separated to obtain drug-free serum and low- and high-dose drug-containing serum of musk-aconite. Passage 3 human ventricular cardiomyocyte line AC16 was divided into three groups and treated with drug-free serum and low- and high-dose drug-containing serum of musk and aconite, respectively. Cell viability was detected using the cell counting kit-8 method. Passage 3 human ventricular cardiomyocyte line AC16 was divided into four groups and treated with PBS, drug-free serum, and low- and high-dose drug-containing serum of musk-aconite, respectively, for 48 hours. Then, tumor necrosis factor α was added to the latter three groups for 4 hours to induce an inflammatory model. Western blot was used to detect the expression of nuclear factor κB inhibitor protein, phosphorylated nuclear factor κB inhibitor protein, nuclear factor κB p65, and nuclear factor κB p50 protein.
RESULTS AND CONCLUSION: (1) A total of 268 prescriptions were identified from the 2020 edition of the Pharmacopoeia of the People's Republic of China. After removing duplicates and irrelevant prescriptions, 88 prescriptions containing 36 Chinese medicinal herbs were selected. The most frequently used herbs were cinnamon, dried ginger, aconite, shallot, and musk. These herbs were predominantly pungent and warm in nature, targeting the heart, kidney, and liver meridians, with a treatment principle of Fangxiang Wentong method (aromatic warm and unblocking method). Association rule analysis identified four strong herb pairings, with high support for "musk-aconite," "cinnamon-dried ginger," "dried ginger-aconite," and "shallot-trichosanthes" (confidence ≥ 90%). Factor analysis extracted four common factors, reflecting the historical TCM treatment philosophy of Fangxiang Wentong method. The four core herb pairs might alleviate cardiac aging by modulating inflammatory signaling pathways, which were correlated with the relatively high proportion of inflammatory markers in cardiac aging. Molecular docking of the "musk-aconite" pair revealed good binding ability and stability between key targets and their corresponding active ingredients. (2) Cell counting kit-8 assay results indicated that the "musk-aconite" pair exhibited high cellular compatibility with drug-containing serum. Western blot analysis revealed that compared with the control group, intervention with tumor necrosis factor α significantly induced phosphorylation of the nuclear factor κB inhibitor protein, leading to the release of the nuclear factor κB dimer (p65/p50) into the cell nucleus, thereby confirming the successful establishment of the inflammatory injury model. However, low- and high-dose musk-aconite drug pair-containing serum intervention significantly inhibited the upregulation of nuclear factor κB inhibitor protein and nuclear factor κB (p65/p50) in the cell nucleus induced by tumor necrosis factor α. To conclude, in traditional Chinese medicine, the treatment of cardiac aging primarily follows the principle of Fangxiang Wentong method, with the musk-aconite pair as the core. This herbal combination may slow the progression of cardiac aging by inhibiting inflammatory signals.

Key words: Fangxiang Wentong method, cardiac inflammaging, drug pairs, medication patterns, musk-aconite, inflammatory signal

中图分类号: